Lotte Chemical Corporation (011170) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Oct, 2026Executive summary
Q1 revenue was KRW 4,901.8bn, down 3.6% YoY; operating loss was KRW 126.6bn and net loss KRW 246.3bn.
EBITDA rose KRW 74.1bn QoQ to KRW 173bn; net loss narrowed from KRW 1,144.2bn in Q4 2024.
Recovery visibility remains limited amid oversupply and policy uncertainty, though gradual YoY improvement is expected as capacity ramp-up pressure eases and feedstock prices stabilize.
Financial highlights
Q1 revenue was KRW 4,901.8bn, up 0.1% QoQ and down 3.6% YoY.
Operating loss was KRW 126.6bn, improving KRW 107.5bn QoQ; EBITDA was KRW 173bn, up KRW 74.1bn QoQ.
Pretax loss was KRW 241.1bn; net loss was KRW 246.3bn, compared with KRW 1,144.2bn in Q4 2024.
Performance benefited from improved spreads, production efficiency and the absence of prior-quarter one-off costs.
Outlook and guidance
Q2 performance is expected to be broadly flat QoQ; Daesan and overseas subsidiary maintenance may limit improvement.
Basic Chemicals expects flat Q2 performance: lower BD prices weigh on profit, while lower naphtha prices in May and June may widen spreads.
2025 petrochemical losses are expected to narrow YoY, with gradual improvement as cost pressure eases and sales prices recover.
Positive cash flow is cautiously projected for 2025; after major projects finish this year, investment may be kept within EBITDA from next year.
Latest events from Lotte Chemical Corporation
- Q2 2024 sales rose, losses narrowed, and strategic investments in hydrogen and batteries continued.011170
Q2 2024 - Impairment losses led to deep 2024 losses, but gradual recovery and asset-light progress are expected.011170
Q4 2024 - Q3 2024 revenue was flat, losses widened, and asset sales and investments continue amid weak demand.011170
Q3 2024 - Losses widened, but recovery is expected as portfolio shifts and new projects progress.011170
Q2 2025 - 2025 saw losses from weak demand and impairments, but recovery is expected through diversification.011170
Q4 2025 - Q3 2025 returned to profit, but 9M results show losses; focus shifts to battery and hydrogen.011170
Q3 2025 - Q2 2026 delivered higher profits and restructuring progress, despite ongoing market risks.011170
Q2 2026 - Q1 2026 returned to profit with KRW 4.99T revenue and KRW 49.6B net income amid ongoing risks.011170
Q1 2026